Your browser doesn't support javascript.
loading
Changes in red blood cells with valproate therapy.
Ozkara, C; Dreifuss, F E; Apperson Hansen, C.
Afiliación
  • Ozkara C; Comprehensive Epilepsy Program, University of Virginia, Charlottesville 22908.
Acta Neurol Scand ; 88(3): 210-2, 1993 Sep.
Article en En | MEDLINE | ID: mdl-8256557
Increase in the red blood cell mean corpuscular volume (MCV), and mean corpuscular haemoglobin (MCH) values in patients receiving Valproate as mono or polytherapy was noted. To investigate this situation 41 epileptic patients were studied on Valproate alone (Group 1) and 20 patients on Valproate added to another antiepileptic drug (AED), (Group 4), and compared with 19 patients on carbamazepine (CBZ) (Group 2) and 12 patients on phenytoin (PHT), (Group 3). The results showed significant rise in MCV values in Groups 1 and 4. The peripheral blood smear and other tests including reticulocyte counts of the patients with abnormal values ruled out macrocytic anemias. We postulate a generalized effect which is the result of alteration in erythrocyte membrane phospholipids.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Valproico / Epilepsia / Eritrocitos Límite: Female / Humans / Male Idioma: En Revista: Acta Neurol Scand Año: 1993 Tipo del documento: Article Pais de publicación: Dinamarca
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Valproico / Epilepsia / Eritrocitos Límite: Female / Humans / Male Idioma: En Revista: Acta Neurol Scand Año: 1993 Tipo del documento: Article Pais de publicación: Dinamarca